StockTipsArenaBeta

SELL Aurobindo Pharma — Sahaj Agrawal, Kotak Securities

SELLAurobindo Pharma
Aurobindo Pharma share price target & all analyst calls

bySahaj Agrawal, Kotak SecuritiesHorizon: NA (inferred Swing (≤2wk))21 Oct 2026via CNBC Awaaz.

Entry₹1,606.2Inferred
Target₹1,540
Total upside +4.12%
Stop loss₹1,660-3.35% risk
CMP₹1,578.815h ago
Active+1.71%+2.46%upside left 12d left
Follow Sahaj Agrawal for new calls(14% target hit, 35 closed calls)Get alertsWatch AUROPHARMA for new buy/sell callsGet alertsSee 104 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 7:35 am IST
1 supporting1 neutral0 opposing
Supports the SELL call (1)

MACD below its signal line — bearish momentum

Technicals · macd·22 Oct · today

Neutral / worth noting (1)

Pharma Q2 Outlook: Pricing pressure, US competition to weigh on select players

NewsEt-Markets·19 Oct · 3d ago

(opens in new tab)
Weighs against the SELL call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aurobindo Pharma

All analyst calls on Aurobindo Pharma

More from Sahaj Agrawal, Kotak Securities

Every call and its outcome